ICU
SeaStar MedicalBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
The constructive case is that SeaStar now has a commercial product with growing revenue, 10 active hospital customers at year-end 2025, encouraging early SAVE registry safety observations, and a longer-duration option on the adult AKI pivotal program if enrollment continues and financing remains available [#10-K-2026-03-25].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Extended timeline and execution risk in the adult NEUTRALIZE-AKI pivotal study
Momentum
72
Value
36
Sentiment
62
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.50 · Bull $7.00 · Bear $1.80
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-19 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $9.00
Why
Momentum72 · Δ7d -
Value36 · Δ7d -0.0
Sentiment62 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
72
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
62
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 72.3 / Value 36.3 / Sentiment 61.7
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$14.11M
Beta
-0.98
Shares Out
3.6M
P/E (TTM) · Derived
-0.1
P/S (TTM)
10.60
P/FCF (TTM) · Derived
-3.53
Rev YoY
+169.1%
EPS YoY
+88.0%
Gross Margin
+95.3%
Op Margin
-1580.5%
Net Debt
-$1.25M
Current Ratio
3.66
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology